SOLENO THERAPEUTICS INC — Operating Income by Fiscal Year
13 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/953e7298-bd6f-4bdc-ad1a-7155ba532630/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $9.4M | 2025-01-01 – 2025-12-31 | evidence 0001193125-26-071808 |
| FY 2024 | $-187.7M | 2024-01-01 – 2024-12-31 | evidence 0000950170-25-029545 |
| FY 2023 | $-41.4M | 2023-01-01 – 2023-12-31 | evidence 0000950170-24-027500 |
| FY 2022 | $-24.4M | 2022-01-01 – 2022-12-31 | evidence 0000950170-23-009211 |
| FY 2021 | $-31.5M | 2021-01-01 – 2021-12-31 | evidence 0001564590-22-013023 |
| FY 2020 | $-36.3M | 2020-01-01 – 2020-12-31 | evidence 0001564590-21-010569 |
| FY 2019 | $-23.5M | 2019-01-01 – 2019-12-31 | evidence 0001564590-20-008705 |
| FY 2018 | $-14.3M | 2018-01-01 – 2018-12-31 | evidence 0001564590-19-008508 |
| FY 2017 | $-12.2M | 2017-01-01 – 2017-12-31 | evidence 0001564590-19-008508 |
| FY 2016 | $-8.3M | 2016-01-01 – 2016-12-31 | evidence 0001193125-18-104048 |
| FY 2015 | $-12.2M | 2015-01-01 – 2015-12-31 | evidence 0001628280-16-013113 |
| FY 2014 | $-5.2M | 2014-01-01 – 2014-12-31 | evidence 0001193125-15-091006 |
| FY 2013 | $-846.8k | 2013-01-01 – 2013-12-31 | evidence 0001193125-15-091006 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).